Non-invasive blood monitoring technology

Founders

Ben Nashman

INDUSTRY

Biotechnology (Healthcare) 

MILESTONE

Radical Investment: 2020

Using magnetic resonance, the same underlying principle used in Magnetic Resonance Imaging (MRI), Synex is building wearable devices that would tell a person, in real time, how their body is performing by measuring glucose, lactate, and ketones – critical metabolites that affect everything from weight gain to athletic performance to the likelihood of developing diabetes.

Glucose monitoring, one the most common monitoring use-cases, currently relies on an antiquated and barbaric approach involving regular pin pricks and test strips. Synex’s combination of machine learning and novel magnetic resonance technology is non-invasive technology that introduces the possibility of an entirely new category of applications to enable everyone to understand their bodies in real-time.

Founders

Tamer Mohamed,
Sam Wadsworth,
Simon Beyer

Founders

Himanshu Gupta,
Max Evans

Founders

Aidan Gomez,
Nick Frosst,
Ivan Zhang

Founders

Pieter Abbeel,
Peter Chen,
Rocky Duan,
Tianhao Zhang

Founders

Fei-Fei Li,
Dr. Arnold Milstein

Founders

Evan Feinberg,
Ben Sklaroff

Founders

Ramtin Attar,
Reza Nasseri

Founders

Rishi Nayyar,
Harsh Nayyar

Founder

Benjamin Schmidt

Founder

Corey Gross

Founder

Ben Nashman

Founders

Martin Snelgrove,
Darrick Wiebe

Founders

Raquel Urtasun

Founders

Christian Weedbrook

© 2021 Radical Ventures Investments Inc.